Biosimilars: Infliximab IV, Tocilizumab IV en SC, Denosumab SC en Epoëtine alfa

Deadline:1 Dec 2026, 09:00

Tender information

Arr. Mechelen

Type

Contract

Procedure

Open procedure

Ref. number

PPP0SD-385/6142/6385

Contract type

Framework agreement

Duration

01/01/2027 - 31/12/2028

Biosimilars: Infliximab IV, Tocilizumab IV en SC, Denosumab SC en Epoëtine alfa

INFLIXIMAB IV

TOCILIZUMAB

DENOSUMAB SC

EPOËTINE ALFA

Buyer

IMELDA VZW

Document name	Upload date	File size
First document.pdf	1 Jan 1970, 00:00	1 Bytes
Second document.pdf	1 Jan 1970, 00:00	1 Bytes

Information on this page originates from the following sources: TED

Buyer

IMELDA VZW

Open for offers

27 days left

Important dates

3 Nov - Publication date

1 Dec - Deadline

Unlock Full Access with Mercell Bidding Business Plus

Start your free trial to explore exclusive features that help you win more tenders, faster:

AI-Powered Tender Insights

Buyer Contact Info

Key Tender Timelines

Already have an account?